Lucira Health, Inc. (LHDX) Misses Q2 EPS by 9c

Lucira Health, Inc. (NASDAQ: LHDX) reported Q2 EPS of ($0.54), $0.09 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $28.43 million.

For earnings history and earnings-related data on Lucira Health, Inc. (LHDX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c